9:22 AM
Leo Group India
| ||
| Auxilium Pharmaceuticals, Inc. to Present At The JMP Securities 2012 ... Business Review India (press release) MALVERN, Pa., July 6, 2012 Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) today announced that executive management will participate in the JMP Securities 2012 Healthcare Conference to be held July 12-13, 2012 at the Peninsula Hotel in New York City. See all stories on this topic » | ||
| India invests $5.4 bn to provide people with free medicines Punjab Newsline By Vipan Kumar India has invested $5.4 billion in a policy to provide free medicine to its people, which can change the lives of hundreds of millions, but a ban on branded drugs blows hard on major pharmaceuticals. See all stories on this topic » | ||
| Pharmaceutical firms to get incentives for child cancer drugs Beaumont Enterprise Legislation by Texas Rep. Michael McCaul, soon to be signed by President Barack Obama, will offer drug companies multimillion-dollar incentives to pioneer medications for rare childhood diseases that afflict too few kids to make a profit. The measure ... See all stories on this topic » | ||
| ||
| Sucampo Pharma's constipation drug, Amitiza gets Japanese approval pharmabiz.com Sucampo Pharma, Ltd., a wholly owned subsidiary of Sucampo Pharmaceuticals, Inc. (SPI) has received approval from the Ministry of Health, Labor and Welfare in Japan for Amitiza (lubiprostone), a prescription medicine for the treatment of chronic ... See all stories on this topic » | ||
| Sucampo Falls After Failing to End Drug Deal With Takeda Bloomberg Sucampo Pharmaceuticals Inc. (SCMP), the maker of the constipation drug Amitiza, dropped the most in about 3 1/2 years after losing a bid in arbitration to sever ties with marketing partner Takeda Pharmaceutical Co. (4502). Sucampo fell 25 percent to ... See all stories on this topic » | ||
| Aoxing Pharmaceutical Company Announces Management Change Business Review India (press release) Ms. Zhou has in depth experience in pharmaceutical research and is responsible for our new drugs applications. Ms. Zhou has around 30 years of research and product development experience and she obtained a lot of awards and achievements in the ... See all stories on this topic » | ||
| SKYSTAR BIO-PHARMACEUTICAL COMPANY : Skystar Announces Crowe ... 4-traders Skystar Announces Crowe Horwath CPA Limited as New Independent Registered Public Accounting Firm XI'AN, CHINA -- -- 07/06/12 -- Skystar... See all stories on this topic » | ||
| Ernst & Young announces Lupin Pharmaceuticals, Inc., CEO Vinita Gupta is the ... Business Review India (press release) BALTIMORE, July 6, 2012 /PRNewswire/ -- Ernst & Young LLP today announced that Ms. Vinita Gupta, CEO of Lupin Pharmaceuticals, Inc., received the Ernst & Young Entrepreneur Of The Year® 2012 Award in the Health Services and Technology category ... See all stories on this topic » | ||
| Pharmaceutical & Medical Devices Industry Executives Project Increased M&A ... Healthcare Global (press release) ROCKVILLE, MD--(Marketwire - July 5, 2012) - MarketResearch.com has announced the addition of the new report "Global Business Survey: M&A Trends and Key Markets for Growth in 2012-2013," to their collection of Pharmaceuticals market reports. See all stories on this topic » |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment